GeneDx Holdings Corp. (WGS) Revenue Growth
GeneDx Holdings Corp. (WGS) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2021-12-31 | 18.33% |
| 2022-12-31 | 10.60% |
| 2023-12-31 | -13.69% |
| 2024-12-31 | 50.79% |
| 2025-12-31 | 39.97% |
How WGS compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| PAHC | Phibro Animal Health Corporation | 27.37% |
| MNKD | MannKind Corporation | 22.23% |
| INCY | Incyte Corporation | 21.22% |
| BSX | Boston Scientific Corporation | 19.87% |
| ENSG | The Ensign Group Inc. | 18.72% |
These are five companies in the same sector as WGS with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get GeneDx Holdings Corp. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("WGS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | WGS | $86.33 | -3.26% | 0.44M |
| 3 | ||||
| 4 | ||||
| 5 |